A beta oligomerization A Therapeutic Target for Alzheimers Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6107|1|1|25-38

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.1, Iss.1, 2001-05, pp. : 25-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 118-121

Bentham Science Publishers

Access to resources Recommend Favorite

RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease

By  

Current Molecular Medicine, Vol. 7, Iss. 8, 2007-12 ,pp. : 735-742

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease

By Wada K.   Nakajima A.   Blumberg R.S.  

Trends in Molecular Medicine, Vol. 7, Iss. 8, 2001-08 ,pp. : 329-331

Elsevier

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Comprehensive Therapy, Vol. 33, Iss. 2, 2007-06 ,pp. : 58-64

Humana Press, Inc

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 653-661

Bentham Science Publishers

Access to resources Recommend Favorite